Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. The company is headquartered in Lakewood, Colorado and currently employs 730 full-time employees. The firm's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.
How did MLAB's recent EPS compare to expectations?
The most recent EPS for Mesa Laboratories Inc is $0.65, beating expectations of $0.28.
How did Mesa Laboratories Inc MLAB's revenue perform in the last quarter?
Mesa Laboratories Inc revenue for the last quarter is $0.65
What is the revenue estimate for Mesa Laboratories Inc?
According to 5 of Wall street analyst, the revenue estimate of Mesa Laboratories Inc range from $68.5M to $63.79M
What's the earning quality score for Mesa Laboratories Inc?
Mesa Laboratories Inc has a earning quality score of B+/56.094997. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Mesa Laboratories Inc report earnings?
Mesa Laboratories Inc next earnings report is expected in 2026-05-04
What are Mesa Laboratories Inc's expected earnings?
Mesa Laboratories Inc expected earnings is $64.62M, according to wall-street analysts.
Did Mesa Laboratories Inc beat earnings expectations?
Mesa Laboratories Inc recent earnings of $65.12M beat expectations.